Loading
Latest filing published 08 Jun 2026 for Aurinia Pharmaceuticals Inc., €232k. Read the official filing
No signal scores available.
One trade, one date: on 8 June 2026, Craig Johnson disclosed an option exercise of €232k in Aurinia Pharmaceuticals Inc. No broader history exists yet. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration